Invesco
PDSB icon

Invesco’s PDS Biotechnology PDSB Stock Holding History

Invesco’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,815
Closed -$52.8K – 3803
2024
Q3 		$52.8K Buy
13,815
+641
+5% +$2.14K ﹤0.01% 3683
2024
Q2 		$38.6K Sell
13,174
-5,355
-29% -$17.1K ﹤0.01% 3841
2024
Q1 		$73.4K Buy
18,529
+280
+2% +$1.44K ﹤0.01% 3772
2023
Q4 		$90.7K Sell
18,249
-1,667
-8% -$8.29K ﹤0.01% 3697
2023
Q3 		$101K Buy
19,916
+2,166
+12% +$11.9K ﹤0.01% 3718
2023
Q2 		$89.3K Buy
+17,750
New +$116K ﹤0.01% 3747
2021
Q4 		– Sell
-329,698
Closed -$4.91M – 4091
2021
Q3 		$4.91M Buy
+329,698
New +$4.11M ﹤0.01% 2393

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco's PDSB Position: Q4 2024 in Review

Invesco sold out of PDS Biotechnology (PDSB) in Q4 2024, closing a stake of 13,815 shares — an estimated $52.8K sold.

Invesco first reported a position in PDSB in Q3 2021 and held it in 7 quarters. The position peaked at $4.91M in Q3 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2024.

  • Invesco reported no remaining PDS Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 13,815 PDS Biotechnology shares in Q4 2024, an estimated $52.8K.
  • Invesco first reported a position in PDS Biotechnology in Q3 2021 and held it in 7 quarters.
  • Invesco's PDS Biotechnology position peaked at $4.91M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.